Fill out the form below, including all contact information and as much detail as possible about your case, and we will contact you upon receipt of your form.

Call Now: 1-866-828-4699


Have you or a loved one used any of these prescription medications?
Digitek
Bertek
Digoxin
Lanoxin
Lanoxicaps
UDL
Caraco Digoxin Tablets
Other
While using the medication, did you or a loved one experience any injuries?
Yes No
What type of injury occurred?
Cardiac Arrest/Injury Yes No
Bradycardia Yes No
Digitalis Toxicity Yes No
Fall injury from fainting or loss of consciousness Yes No
Death Yes No
Overdose Yes No
Nausea, vomiting, dizziness Yes No
Low blood pressure Yes No
OtherYes No
Was a trip to the Emergency Room or hospital necessary?
Yes No
Are you currently represented by a lawyer?
Yes No
First Name:
Last Name:
Address:
City:
State:
Zip:
Phone:
E-mail:

Tell us about your case:




Heart Medications Recalled.
You or a loved one may be entitled to financial compensation if injury or death occurred while taking these medicines.

On April 28, 2008, drug manufacturer Actavis Totowa, LLC issued a Class I nationwide recall of all Digitek® Digoxin tablets distributed between March 2006 and April 2008. The pills may contain two times the acceptable dosage of the active ingredient.

On March 31, 2009, Caraco Pharmaceutical Laboratories, Ltd. and the FDA notified healthcare professionals of a recall of Caraco brand Digoxin (generic for Digitek®), USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September 2011. Likewise, on May 11, 2009, AS Medications Solutions, LLC, a drug repackaging company, announced a nationwide recall of Caraco brand Digoxin tablets, USP, 0.25 mg, which are not expired and within the expiration date of August 2011. The Caraco brand Digoxin tablets were recalled because of concerns that the tablets may have contained too much or too little of the active ingredient, Digoxin.

Class I recalls are conducted when DANGEROUS or DEFECTIVE products could cause serious health problems or death if released.

Both Digoxin and Digitek® and Caraco brand Digoxin tablets are prescribed for treatment of heart failure and abnormal heart rhythms. The existence of double-strength tablets poses a risk of digitalis toxicity. This could lead to serious and potentially fatal illness caused by overmedication, especially among individuals with renal insufficiencies.

Digitalis toxicity can cause among other things:

  • Death or hospitalization
  • Visual changes, changes in color perception -yellow-green distortion is most common, but red, brown, blue, and white also occur-halos, bright spots, blind spots, blurred vision
  • Palpitations
  • Irregular pulse, bradycardia (slow heart rate below 60 bpm)
  • Dizziness, loss of consciousness
  • Low blood pressure
  • Loss of appetite
  • Nausea/ vomiting
  • Decreased urine output
  • Excessive nighttime urination
  • Cold sweats
  • Difficulty breathing when lying down

Taking a tablet with too little Digoxin could result in cardiac instability due to lack of efficacy.

If you believe that you or a loved one has suffered hospitalization or death as a result of taking Digitek® or Caraco brand Digoxin, fill out our online form or call us toll free at 1-866-828-4699.

For more information, contact the Onder Law Firm.

Onder, Shelton, O’Leary & Peterson, LLC
1-866-828-4699
www.onderlaw.com

The choice of a lawyer is an important decision and should not be based solely upon advertisements.